Vol 2005, No 61 (2005)

Table of Contents

Deal Trackers

Dacogen (decitabine) Abstract pdf
Business Review Editor

Research & Development

Novartis and Hybridon to Develop Oligonucleotides for Asthma and Allergy Abstract pdf
Business Review Editor
Exelixis and Genentech Forge R&D Pact Abstract pdf
Business Review Editor

Features

Serono Continues its Deal Making Spree through Collaborations with BioMarin and NovImmune Abstract pdf
Business Review Editor
Anadys Lands Lucrative HCV Deal with Novartis Abstract pdf
Business Review Editor
Royalty Rates Used in Pharmaceutical Agreements Abstract pdf
Business Review Editor
Therapy Focus: Cystic Fibrosis Abstract pdf
Business Review Editor

Licensing

Merck Obtains License from BioXell to Develop TREM-1 Products Abstract pdf
Business Review Editor
Cephalon Acquires Cancer Drug Trisenox® from Cell Therapeutics Abstract pdf
Business Review Editor

General

Renovis and Pfizer Enter Substantial Agreement Abstract
Business Review Editor
Vectura Group plc Abstract pdf
Business Review Editor

Mergers & Acquisitions

Pfizer Broadens Anti-Infectives Business through Acquisition of Vicuron Abstract pdf
Business Review Editor

Business Commentaries

Don't Make Your Drug Deals Poison Pills html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.